Efficacy of topical pale sulfonated shale oil in the treatment of venous leg ulcers:: A randomized, controlled, multicenter study

被引:12
|
作者
Beckert, S
Warnecke, J
Zelenkova, H
Kovnerystyy, O
Stege, H
Cholcha, W
Königsrainer, A
Coerper, S
机构
[1] Univ Tubingen Hosp, Dept Gen & Transplantsurg, Tubingen, Germany
[2] Ichthyol Gesell Cordes Hermanni & Co GmbH & Co KG, Hamburg, Germany
[3] DOST Svidnik, Svidnik, Slovakia
[4] Univ Hosp, Dept Dermatol, Dusseldorf, Germany
关键词
D O I
10.1016/j.jvs.2005.09.028
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Venous leg ulcers are a growing socioeconomic burden. Pale sulfonated shale oils (PSSO) are used for therapy of inflammatory skin diseases and have been shown to enhance wound healing in vitro and in vivo. The aim of this study was to investigate whether PSSO is capable of enhancing venous ulcer healing beyond compression therapy alone. Methods. One hundred nineteen patients were enrolled in this randomized, multicenter, observer-blind study. In the treatment group, PSSO 10% was applied daily for 20 weeks, and the control group received the vehicle only. Wounds were covered by a nonadherent gauze dressing, and compression therapy with short-stretch elastic bandages was performed in an outpatient setting. The primary study end point was defined as cumulative reduction in wound area; the secondary study end point was treatment success as assessed by both physicians and patients. Additionally, adverse events, including changes with respect to physical examination and vital signs, were documented. Results. At the end of the study period, ulcer size was significantly more reduced in the PSSO group compared with the vehicle group (15 +/- 15.9 to 6.2 +/- 12.9 cm(2) vs 11.4 +/- 14.5 to 10.8 +/- 15.7 cm(2); P =.0005). The cumulative relative reduction in ulcer area was significantly higher in the PSSO group (-4391 +/- 4748.7 vs -231.9 +/- 6283.6 % X days; P <.0001). Relative reduction in wound area was significantly greater in the PSSO group as early as 6 weeks after the beginning of treatment (-47.4 +/- 28.4 vs -23.8 +/- 42.2%; P <.001). PSSO was judged successful both by physicians and patients. There were no significant differences in adverse events (PSSO, 9 [12.2%]; vehicle, 7 [11.1%]. Similarly, tolerability of PSSO was equal to the tolerability of the vehicle. Conclusion: Pale sulfonated shale oils were capable of favoring venous ulcer healing in addition to compression therapy. PSSO should be considered for future wound care protocols for treatment of venous leg ulcers.
引用
收藏
页码:94 / 100
页数:7
相关论文
共 50 条
  • [31] TOPICAL TREATMENT OF VENOUS LEG ULCERS WITH A PROSTACYCLIN HYDROGEL - A DOUBLE-BLIND TRIAL
    WERNERSCHLENZKA, H
    LEHNERT, W
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1994, 51 (03): : 203 - 206
  • [32] Topical Application of Manuka Honey for the Treatment of Non-Healing Venous Leg Ulcers
    Kucharzewski, Marek
    Spyrka, Kinga
    Rojczyk, Ewa
    Brela, Jakub
    PHARMACEUTICALS, 2025, 18 (02)
  • [33] A Lower Leg Physical Activity Intervention for Individuals With Chronic Venous Leg Ulcers: Randomized Controlled Trial
    Kelechi, Teresa J.
    Prentice, Margaret A.
    Mueller, Martina
    Madisetti, Mohan
    Vertegel, Alexey
    JMIR MHEALTH AND UHEALTH, 2020, 8 (05):
  • [34] Conservative versus surgical treatment of venous leg ulcers: 10-year follow up of a randomized, multicenter trial
    van Gent, W. B.
    Catarinella, F. S.
    Lam, Y. L.
    Nieman, F. H. M.
    Toonder, I. M.
    van der Ham, A. C.
    Wittens, C. H. A.
    PHLEBOLOGY, 2015, 30 : 35 - 41
  • [35] A STUDY OF THE EFFECT OF CADEXOMER IODINE IN THE TREATMENT OF VENOUS LEG ULCERS
    HARCUP, JW
    SAUL, PA
    BRITISH JOURNAL OF CLINICAL PRACTICE, 1986, 40 (09): : 360 - 364
  • [36] Early and long-term results of physical methods in the treatment of venous leg ulcers: randomized controlled trial
    Taradaj, J.
    Franek, A.
    Cierpka, L.
    Brzezinska-Wcislo, L.
    Blaszczak, E.
    Polak, A.
    Chmielewska, D.
    Krol, P.
    Dolibog, P.
    Kucio, C.
    PHLEBOLOGY, 2011, 26 (06) : 237 - 245
  • [37] Treatment of recalcitrant venous leg ulcers with autologous keratinocytes in fibrin sealant:: A multinational randomized controlled clinical trial
    Vanscheidt, W.
    Ukat, A.
    Horak, V.
    Bruening, H.
    Hunyadi, J.
    Pavlicek, R.
    Emter, M.
    Hartmann, A.
    Bende, J.
    Zwingers, Th.
    Ermuth, T.
    Eberhardt, R.
    WOUND REPAIR AND REGENERATION, 2007, 15 (03) : 308 - 315
  • [39] A randomized controlled trial of larval therapy for the debridement of leg ulcers: Results of a multicenter, randomized, controlled, open, observer blind, parallel group study
    Mudge, Elizabeth
    Price, Patricia
    Neal, Walkley
    Harding, Keith G.
    WOUND REPAIR AND REGENERATION, 2014, 22 (01) : 43 - 51
  • [40] Topical Treatment of Hypertensive Leg Ulcers With Platelet-Derived Growth Factor-BB A Randomized Controlled Trial
    Senet, Patricia
    Vicaut, Eric
    Beneton, Nathalie
    Debure, Clelia
    Lok, Catherine
    Chosidow, Olivier
    ARCHIVES OF DERMATOLOGY, 2011, 147 (08) : 926 - 930